Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy-Reference-Cited by-同舟云学术

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

Published:2014-02 Issue:2 Volume:25 Page:152-165
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Choi Woonyoung,Porten Sima,Kim Seungchan,Willis Daniel,Plimack Elizabeth R.,Hoffman-Censits Jean,Roth Beat,Cheng Tiewei,Tran Mai,Lee I-Ling,Melquist Jonathan,Bondaruk Jolanta,Majewski Tadeusz,Zhang Shizhen,Pretzsch Shanna,Baggerly Keith,Siefker-Radtke Arlene,Czerniak Bogdan,Dinney Colin P.N.,McConkey David J.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference44 articles.

1. Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARgamma by FABP4;Ayers;Biochemistry,2007

2. Bladder cancer outcome and subtype classification by gene expression;Blaveri;Clin. Cancer Res.,2005

3. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck;Boldrup;J. Pathol.,2007

4. The health economics of bladder cancer: a comprehensive review of the published literature;Botteman;Pharmacoeconomics,2003

5. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine;Celis;J. Urol.,1996

Cited by 1357 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein-Based Predictive Biomarkers to Personalize Neoadjuvant Therapy for Bladder Cancer—A Systematic Review of the Current Status;International Journal of Molecular Sciences;2024-09-13

2. Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder;BJUI Compass;2024-09-10

3. Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features;Cancer Research Communications;2024-09-01

4. Contemporary Molecular Markers for Predicting Systemic Treatment Response in Urothelial Bladder Cancer: A Narrative Review;Cancers;2024-09-01

5. Unbiased discovery of cancer pathways and therapeutics using Pathway Ensemble Tool and Benchmark;Nature Communications;2024-08-24